← Leaderboards
Dorothy J. Wiley
University Of California Los Angeles
$3,612,678
Attributed
$3,612,678
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $973.9K · FY2006–17$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$3,612,678 · 4
By mechanism
R01$3,124,885 · 1
R21$484,645 · 1
M01$3,148 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Ronald T Mitsuyasu$121,811,876
- Steven Nusinowitz$1,264,092
- Grace Hyun Jung Kim$1,270,727
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionConsensusDiagnosticAlgorithmsHuman Papilloma Virus InfectionMorbidity - Disease RateDysplasiaMalignant Neoplasm Of AnusHpv-High RiskVisitMalignant Neoplasm Of Cervix UteriMalignant NeoplasmsAnusMen Who Have Sex With MenPreventBisexualCharacteristicsGaysTransgenderBiological MarkersMortality Vital StatisticsHuman PapillomavirusAtypical Squamous CellAtypia
Grant awards (10)
Improving screening tools to better predict high-grade anal dysplasia for MSM$431,501
R01 · FY2017 · CA · contact PI
Improving screening tools to better predict high-grade anal dysplasia for MSM$531,474
R01 · FY2016 · CA · contact PI
Improving screening tools to better predict high-grade anal dysplasia for MSM$973,939
R01 · FY2015 · CA · contact PI
Improving screening tools to better predict high-grade anal dysplasia for MSM$583,995
R01 · FY2014 · CA · contact PI
Improving screening tools to better predict high-grade anal dysplasia for MSM$603,976
R01 · FY2013 · CA · contact PI
Methylation and Related Anogenital HPV Cancers$148,469
R21 · FY2009 · CA · contact PI
Methylation and Related Anogenital HPV Cancers$185,374
R21 · FY2008 · CA · contact PI
Methylation and Related Anogenital HPV Cancers$150,802
R21 · FY2007 · CA · contact PI
PHASE II CLINICAL STUDIES OF CHEMOPREVENTION AGENTS - WORKSTATEMENT 80: AN EX$2,748
M01 · FY2007 · RR · contact PI
PHASE II CLINICAL STUDIES OF CHEMOPREVENTION AGENTS - WORKSTATEMENT 80: AN EX$400
M01 · FY2006 · RR · contact PI